[go: up one dir, main page]

WO2001075001A3 - A novel polypeptide, cyclic adenosine 9-dependant human protein kinase and the polynucleotide encoding the polypeptide - Google Patents

A novel polypeptide, cyclic adenosine 9-dependant human protein kinase and the polynucleotide encoding the polypeptide Download PDF

Info

Publication number
WO2001075001A3
WO2001075001A3 PCT/CN2001/000254 CN0100254W WO0175001A3 WO 2001075001 A3 WO2001075001 A3 WO 2001075001A3 CN 0100254 W CN0100254 W CN 0100254W WO 0175001 A3 WO0175001 A3 WO 0175001A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
dependant
polynucleotide encoding
protein kinase
human protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/000254
Other languages
French (fr)
Chinese (zh)
Other versions
WO2001075001A2 (en
Inventor
Yumin Mao
Yi Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Biowindow Gene Development Inc
Original Assignee
Shanghai Biowindow Gene Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Development Inc filed Critical Shanghai Biowindow Gene Development Inc
Priority to AU46303/01A priority Critical patent/AU4630301A/en
Publication of WO2001075001A2 publication Critical patent/WO2001075001A2/en
Publication of WO2001075001A3 publication Critical patent/WO2001075001A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention discloses a novel polypeptide, a cyclic adenosine 9 dependant human protein kinase, the polynucleotide encoding the polypeptide and the method for producing the polypeptide by DNA recombinant technology. The invention also discloses the uses of the polypeptide in methods for treating various diseases, such as malignant tumor, hemopathy, HIV infection, immunological disease, and various inflammation, etc. The invention also discloses the agonists against the polypeptide and the therapeutic action thereof. The invention also discloses the uses of the polynucleotide encoding the cyclic adenosine 9-dependant human protein kinase.
PCT/CN2001/000254 2000-03-02 2001-02-26 A novel polypeptide, cyclic adenosine 9-dependant human protein kinase and the polynucleotide encoding the polypeptide Ceased WO2001075001A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU46303/01A AU4630301A (en) 2000-03-02 2001-02-26 A novel polypeptide, cyclic adenosine 9-dependant human protein kinase and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN00111864.1 2000-03-02
CN 00111864 CN1311243A (en) 2000-03-02 2000-03-02 New polypeptide-human cAMP dependent protein kinase regulation subunit 9 and polynucleotide for coding such polypeptide

Publications (2)

Publication Number Publication Date
WO2001075001A2 WO2001075001A2 (en) 2001-10-11
WO2001075001A3 true WO2001075001A3 (en) 2002-03-07

Family

ID=4581760

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000254 Ceased WO2001075001A2 (en) 2000-03-02 2001-02-26 A novel polypeptide, cyclic adenosine 9-dependant human protein kinase and the polynucleotide encoding the polypeptide

Country Status (3)

Country Link
CN (1) CN1311243A (en)
AU (1) AU4630301A (en)
WO (1) WO2001075001A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446064A (en) * 1980-12-19 1984-05-01 The University Of Virginia Alumni Patents Foundation Insulin mediator substance
US5922844A (en) * 1996-06-21 1999-07-13 Incyte Pharmaceuticals, Inc. Human cAMP-dependent protein kinase inhibitor homolog

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446064A (en) * 1980-12-19 1984-05-01 The University Of Virginia Alumni Patents Foundation Insulin mediator substance
US5922844A (en) * 1996-06-21 1999-07-13 Incyte Pharmaceuticals, Inc. Human cAMP-dependent protein kinase inhibitor homolog

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 1 November 1998 (1998-11-01), BIRREN B. ET AL., Database accession no. AC005696 *
DATABASE GENBANK [online] 9 October 1999 (1999-10-09), MUZNY D. ET AL., Database accession no. AC008008 *

Also Published As

Publication number Publication date
WO2001075001A2 (en) 2001-10-11
CN1311243A (en) 2001-09-05
AU4630301A (en) 2001-10-15

Similar Documents

Publication Publication Date Title
WO2001075001A3 (en) A novel polypeptide, cyclic adenosine 9-dependant human protein kinase and the polynucleotide encoding the polypeptide
WO2001075036A3 (en) A novel polypeptide, human immunophiline 14 and the polynucleotide encoding the polypeptide
WO2001075043A3 (en) A novel polypeptide, dna-dependent human protein kinase 9 and the polynucleotide encoding the polypeptide
WO2001094529A3 (en) A novel polypeptide, a human atp dependant serine proteinase 21 and the polynucleotide encoding the polypeptide
WO2002000821A3 (en) A novel polypeptide, a human protein plp39 and the polynucleotide encoding the polypeptide
WO2001075011A3 (en) A novel polypeptide, cytochrome human constitution protein 10 and the polynucleotide encoding the polypeptide
WO2001075058A3 (en) A NOVEL POLYPEPTIDE, HUMAN AMINOACYL-tRNA SYNTHETASE 15 TYPE II AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
WO2001079431A3 (en) A novel polypeptide, a human pathway 15 protein with the huntingtine protein and the polynucleotide encoding the polypeptide
WO2001075016A3 (en) A novel polypeptide, a human tyrosinase 16, and the polynucleotide encoding the polypeptide
WO2001075048A3 (en) A novel polypeptide, human ribosomal protein s11 23 and the polynucleotide encoding the polypeptide
WO2001075035A3 (en) A novel polypeptide, human peroxydase protein 9 and the polynucleotide encoding the polypeptide
WO2001075034A3 (en) A novel polypeptide, human peroxydase protein 15 and the polynucleotide encoding the polypeptide
WO2001075057A3 (en) A novel polypeptide, human ribosomal s4 protein 12 and the polynucleotide encoding the polypeptide
WO2001083682A3 (en) A novel polypeptide, a human pax protein 11.6 and the polynucleotide encoding the polypeptide
WO2001083687A3 (en) A novel polypeptide, a human pax protein 23 and the polynucleotide encoding the polypeptide
WO2001075024A3 (en) A novel polypeptide, nf-e2-associated human factor 13 and the polynucleotide encoding the polypeptide
WO2002000828A3 (en) A novel polypeptide, a zinc-finger protein 34 and the polynucleotide encoding the polypeptide
WO2001083681A3 (en) A novel polypeptide, a human dihydroorotase 21 and the polynucleotide encoding the polypeptide
WO2001075039A3 (en) A novel polypeptide, human rna helicase 10 and the polynucleotide encoding the polypeptide
WO2002000823A3 (en) A novel polypeptide, a enzymatic activation protein ras gtp 9.57 and the polynucleotide encoding the polypeptide
WO2001094540A3 (en) A novel polypeptide, a human glucosyl hydrolase 23 and the polynucleotide encoding the polypeptide
WO2001075028A3 (en) A novel polypeptide, human ribosomal protein s4-12 and the polynucleotide encoding the polypeptide
WO2001081536A3 (en) A novel polypeptide, a human ysk1 kinase protein 10, and the polynucleotide encoding the polypeptide
WO2001075032A3 (en) A novel polypeptide, human glycinamide ribonucleotide synthetase 10 and the polynucleotide encoding the polypeptide
WO2001064866A1 (en) A novel polypeptide, a ribosome s19e protein 11 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP